Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$29 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0757
D

Failure to Monitor Antipsychotic Target Behaviors and Side Effects

Henderson, Nevada Survey Completed on 03-04-2026

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to ensure that a resident’s antipsychotic drug regimen was monitored for target behaviors and side effects as required. A cognitively intact resident admitted with diagnoses including metabolic encephalopathy, malignant neoplasm of the colon, and non‑traumatic subarachnoid hemorrhage was receiving Quetiapine 25 mg at bedtime for bipolar disorder manifested by mood swings. The admission MDS documented verbally aggressive behaviors and antipsychotic use. A physician order dated 04/15/2025 initiated Quetiapine, but the medical record lacked documented evidence that target behaviors or side effects were monitored from 04/15/2025 through 04/28/2025, despite facility policy that residents admitted on antipsychotics be evaluated for appropriateness and indication for use by the IDT and physician. On 04/29/2025, physician orders were entered to monitor mood swings as the target behavior and to use specified non‑pharmacological interventions with outcome codes every shift, as well as to monitor for specific side effects of Quetiapine (including dry mouth, constipation, blurred vision, confusion, hypotension, EPS, and others) every shift. Interviews with an LPN and a charge nurse confirmed that Quetiapine had been administered starting 04/15/2025 and that behavior and side effect monitoring did not begin until 04/29/2025, likely because the admitting nurse did not enter the monitoring orders at the time the medication was started. The charge nurse explained that if orders are not entered into the EHR, floor nurses are not prompted to complete related tasks. The DON confirmed that the resident was not monitored for target behaviors or potential side effects from the first dose of Quetiapine on 04/15/2025 until 04/29/2025 due to the late entry of monitoring orders, despite facility policy requiring monitoring to guide decisions about continued use, dosage, and GDR of antipsychotic medications.

Long-term care team reviewing survey readiness and plan of correction

We Help Long-Term Care Teams Stay Survey-Ready

We process and analyze inspection reports and plan of correction using AI to extract insights and trends so providers can improve care quality and stay ahead of compliance risks.

Discover our solutions:

An unhandled error has occurred. Reload 🗙